Although NT-proBNP is a valuable biomarker in HF, it may have limitations in HFpEF due to confounding effects from prevalent comorbidities such as AF, obesity, and renal impairment. The gene discussed is NPPB; the disease is obesity due to melanocortin 4 receptor deficiency.